Plasma clearance of 99Tcm-MAG3: accuracy of five single-sample methods.

Nucl Med Commun

Department of Clinical Physiology and Nuclear Medicine, Aarhus University Hospital, Section Skejby Hospital, Denmark.

Published: February 2000

The aim of this study was to compare the accuracy of five single-injection, single-sample methods for the assessment of plasma clearance of 99Tcm-MAG3 in adults. In 51 patients, a reference plasma clearance was determined on the basis of 16 blood samples. It ranged from 13 to 313 ml.min-1. In patients with a plasma clearance less than 75 ml.min-1, there was a large difference between the clearance obtained by a single-sample method and the reference method. Thus single-sample methods should not be used with these patients. In patients with a plasma clearance higher than 75 ml.min-1, the relative difference was (mean +/- s): 6.07 +/- 9.96% (Russell et al., 1989), 14.22 +/- 8.08% (Müller-Suur et al., 1991), 7.29 +/- 6.21% (Bubeck et al., 1992), 6.64 +/- 7.71% (Russell et al., 1996) and 17.39 +/- 7.39% (Piera et al., 1997). Reference clearance was overestimated by all five single-sample methods, especially by the methods of Müller-Suur et al. and Piera et al. The smallest standard deviation was obtained using the method of Bubeck et al. This method is recommended for use in patients with a plasma clearance greater than 75 ml.min-1.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00006231-200002000-00012DOI Listing

Publication Analysis

Top Keywords

plasma clearance
24
single-sample methods
16
patients plasma
12
clearance 99tcm-mag3
8
clearance
7
plasma
6
+/-
6
single-sample
5
methods
5
patients
5

Similar Publications

Long-lived cytokinetic bridges coordinate sister-cell elimination in mouse embryos.

Dev Cell

January 2025

Centre de recherche du Centre Hospitalier de I'Université de Montréal (CRCHUM), Montréal, QC H2X 0A9, Canada; Department of Obstetrics and Gynaecology, and Department of Pathology and Cell Biology, Université de Montréal, Montréal, QC H3T 1C5, Canada. Electronic address:

Apoptosis is a key feature of preimplantation development, but whether it occurs in a cell-autonomous or coordinated manner was unknown. Here, we report that plasma membrane abscission, the final step of cell division, is profoundly delayed in early mouse embryos such that a cytokinetic bridge is maintained for the vast majority of the following interphase. Early embryos thus consist of many pairs of sister cells connected by stable cytokinetic bridges that allow them to share diffusible molecules.

View Article and Find Full Text PDF

Evaluation of drug-drug interaction between rosuvastatin and tacrolimus and the risk of hepatic injury in rats.

Naunyn Schmiedebergs Arch Pharmacol

January 2025

Department of Organ Transplantation, The Second Affiliated Hospital of Nanchang University, Minde Road No. 1, Nanchang, 330006, Jiangxi, China.

Multimorbidity, therapeutic complexity, and polypharmacy, which greatly increases the risk of drug-drug interactions (DDIs) and adverse medical outcomes, have become important and growing challenges in clinical practice. Statins are frequently prescribed to manage post-transplant dyslipidemia and reduce overall cardiovascular risk in solid organ transplant recipients. This study aimed to determine whether rosuvastatin has significant DDIs with tacrolimus (the first-line immunosuppressant) and to evaluate the risk of hepatotoxicity associated with concomitant therapy.

View Article and Find Full Text PDF

Background: Salbutamol, a short-acting β-agonist used in asthma treatment, is available in multiple formulations, including inhalers, nebulizers, oral tablets, and intravenous, intramuscular, and subcutaneous routes. Each formulation exhibits distinct pharmacokinetic (PK) and pharmacodynamic (PD) profiles, influencing therapeutic outcomes and adverse effects. Although asthma management predominantly relies on inhaled salbutamol, understanding how these formulations interact with patient-specific characteristics could improve personalized medicine approaches, potentially uncovering the therapeutic benefits of alternative formulations for an individual patient.

View Article and Find Full Text PDF

Background: The incidence and mortality of anal squamous cell carcinoma (ASCC) are rising, with greater than 80% of cases linked to human papillomavirus (HPV), primarily HPV16. Post-treatment surveillance can be challenging due to the limitations of anoscopy, digital anal rectal exam (DARE), and imaging. Plasma tumor tissue modified viral (TTMV)-HPV DNA has shown strong sensitivity, specificity, and predictive value in detecting the recurrence of HPV-driven oropharyngeal cancer.

View Article and Find Full Text PDF

Targeting NF-kappaB-inducing kinase shapes B-cell homeostasis in myasthenia gravis.

J Neuroinflammation

January 2025

Department of Neurology, Affiliated Hospital of Xuzhou Medical University, No. 99 Huaihai West Road, Quanshan District, Xuzhou, Jiangsu, China.

Background: B cell immune dysregulation plays a critical role in myasthenia gravis (MG). However, targeted B-cell therapy such as rituximab may result in long-term peripheral B cell clearance and allow for the survival of plasma cells, contributing to frequent infections and relapses. Therefore, we aimed to identify potential novel therapeutic targets that preserve part of B cell function while inhibiting antibody-secreting cells (ASCs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!